Toremifene Citrate Tablets | Breast cancer | HK Drug Wholesale Distributor

Toremifene Citrate Tablets Application Scope

Toremifene citrate is a selective estrogen receptor modulator (SERM) used primarily in the treatment of breast cancer. It is an alternative to tamoxifen in certain cases and is also used for hormone-sensitive breast cancer, where estrogen promotes tumor growth.

Toremifene citrate Tablets Characteristics

Ingredients: Each tablet contains 60 mg of Toremifene.Characteristics: Treatment of metastatic breast cancer

Specification: 60mg

Packing specification: 60mg*30 tablets/box.

Storage: Store at room temperature, away from children.

Expiry date: 24 months

Executive Standard: WS-089(X-076)2002

Approval number: State Drug License H20061284

Revision date: According to the latest drug instruction.

Manufacturer: Ningbo Tianheng Pharmaceutical

 

Guidelines For The Use Of Toremifene Citrate Tablets

Dosage and Administration: The recommended dose is 1 tablet (60 mg) once daily. Patients with renal insufficiency: no dosage adjustment is required.
Hepatic impairment: Toremifene should be taken with caution
ADVERSE REACTIONS: Common adverse reactions are facial flushing, excessive sweating, uterine bleeding, leukorrhea, fatigue, nausea, rash, pruritus, dizziness, and depression.

Toremifene Citrate Tablets Medication Restrictions

Contraindications: Prolonged administration of Toremifene citrate is contraindicated in patients with preexisting endometrial hyperplasia or severe liver failure. Contraindicated in persons with known hypersensitivity to Toremifene citrate and excipients.
Precautions: Gynecological examination prior to treatment to critically check for pre-existing endometrial abnormalities. Subsequent gynecological examinations are performed at least once a year. Patients with bone metastases may develop hypercalcemia at the beginning of treatment and should be monitored.

 

Toremifene Citrate Tablets Interactions

Not known. Before starting treatment, inform your doctor of all medications you are using.

 

Note:

• If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from HongKong DengYue Medicine, China Drug Import and Export Wholesaler.
  It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.